Notice of danger to human health or safety and risk mitigation for Class 3B and Class 4 handheld portable lasers

Last updated: July 4, 2023

Health Canada's mandate includes helping to protect the public by addressing or preventing dangers to human health or safety posed by consumer products. For that purpose, Health Canada's Consumer Product Safety Program (CPSP) administers and enforces the Canada Consumer Product Safety Act (CCPSA) and its regulations.

Danger to human health or safety

Health Canada has assessed the hazards associated with the use of handheld portable lasers of Class 3B or Class 4. These products may pose an eye injury hazard to children, adult users and bystanders.

Based on the danger to human health or safety assessment, Health Canada has determined that Class 3B or Class 4 handheld portable lasers classified in accordance with IEC 60825-1:2014 – Safety of laser products – Part 1: Equipment classification and requirements pose a danger to human health or safety.

Risk mitigation

Based on the information currently available, IEC 60825-1:2014 – Safety of laser products – Part 1: Equipment classification and requirements, sets out criteria that may be sufficient to mitigate the risk of eye injury, including:

The criteria outlined above, in addition to the following modification, may be sufficient to mitigate the risk of eye injury:

Class 3B lasers are described by the International Electrotechnical Commission (IEC) as:

Class 4 lasers are described by the IEC as:

You can find additional details about the scope of products affected and the hazard in the danger to human health or safety assessment.

Responsibilities

Manufacturers, importers, advertisers and retailers are reminded that:

Health Canada may take immediate compliance and enforcement actions in line with the Department's compliance and enforcement policy framework when it has reasonable grounds to believe that a consumer product is a danger to human health or safety. Regulated parties that fail to comply voluntarily may be subject to enforcement actions under the CCPSA, which may include seizure, orders to take corrective measures, orders to recall products, administrative monetary penalties, or criminal prosecution.

Health Canada will continue to monitor the situation and may update this Notice and the associated Danger to Human Health or Safety Assessment as warranted.

Information resources

If you require additional information regarding this Notice, visit the resources below or contact a Health Canada Consumer Product Safety Office via email (hc.ccpsa-lcspc.sc@canada.ca) or telephone at 1-866-662-0666 (toll-free within Canada and the United States).

Subscribe to our electronic newsletter so that you can receive the latest news and information about Health Canada's work in the area of consumer product safety.

Page details

Date modified: